Zdrowie i gospodarka · 28/07/2003

FDA Publishes Guidance for Breast Lesion Documentation System

The Food and Drug Administration (FDA) has released a guidance document outlining requirements for breast lesion documentation systems to comply with special controls for Class II devices, following a recent classification into Class II by a final rule published in the Federal Register.